The prevalence of silent arrhythmia in patients receiving cisplatin-based chemotherapy

Turkish Journal of Cancer

Volumn 38, Issue 1, 2008, Pages 12-15

  Yavaş, Özlem ^a   Aytemir, Kudret ^a   Çelik, Ismail ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Arrhythmia; Cardiotoxicity; Cisplatin

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CANCER CHEMOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROLYTE BLOOD LEVEL; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; LUNG CANCER; MALE; MULTIPLE CYCLE TREATMENT; NEOPLASM; PREVALENCE; QT DISPERSION; TREATMENT OUTCOME;

EID: 46849104061     PISSN: 10193103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Eskilsson J, Albertsson M, Mercke C. Adverse cardiac effects during induction chemotherapy treatment with cisplatin and 5-fluorouracil. Radiother Oncol 1988;13:41-6.
2. Hashimi LA, Khalyl MF, Salem PA. Supraventricular tachycardia, a probable complication of platinum treatment. Oncology 1984; 41:174-5.
3. Tassinari D, Sartori S, Drudi G, et al. Cardiac arrhythmias after cisplatin infusion: three case reports and a review of literature. Ann Oncol 1997;8:1263-7.
4. Schlaeffer F, Tovi F, Leiberman A. Cisplatin induced bradycardia. Drug Intel Clin Pharmacol 1983;17:899-900.
5. Menard O, Martinet Y, Lamy P. Cisplatin induced atrial fibrillation. J Clin Oncol 1991;9:192-3.
6. Altundag O, Celik I, Kars A. Recurrent asymptomatic bradycardia episodes after cisplatin infusion. Ann Pharmacother 2001;35:641-2.
7. Villani F, Misrachi D, Galimberti M. Cardiac arrhythmia and ischaemic events after combination chemotherapy for testicular cancer. Eur Heart J 1994;15:1533-6.
8. Comazzi R, Misrachi D, Galimberti M, et al. Detection of cardiac arrhythmias and ischaemic events in chemotherapy with cisplatin, etoposide and bleomycin for testicular cancer. Anticancer Res 1989;9:663-6.
9. Tonniretti M, Rinudi R, Pulici S, et al. Ischemic cardiopathy from cis-diamminedichloroplatinum (CDDP). Tumori 1984;70:235-6.
10. Berul CL, Sweeten TL, Hill SL, et al. Provocative tests in children with suspect congenital long QT syndrome. Ann Noninvas Electrocardiol 1998;3:3-11.
11. Shimizu W and Antzelevitch C. Cellular basis for long QT, transmural dispersion of repolarization and torsade de pointes in the long QT syndrome. J Electrocardiol 1999;32(suppl):177-84.
12. Averbukh Z, Rosenberg R, Galperin E, Berman S. and et al. Cell-associated magnesium and QT dispersion in hemodialysis patients. Am J Kidney Dis 2003;41:196-202.
13. Touze JE, Heno P, Fourcade L, et al. The effects of antimalarial drugs on ventricular repolarization. Am J Trop Med Hyg 2002;67:54-60.
14. Mathis AS, Gandhi AJ. Serum quinidine concentrations and effect on dispersion and interval. Ann Pharmacother 2002;36:1156-61.
15. Antzelevitch C. Molecular biology and cellular mechanisms of Brugada and Long QT syndromes in infants and young children. J Electrocardiol 2001;34(suppl):177-81.
16. Wang SH, Lin CY, Huang TY, et al. QT interval effects of cisapride in the clinical setting. Int J Cardiol 2001;80:2-3.